CEO of The Medicines Co (MDCO, Financial) Mark Timney bought 26,863 shares of MDCO on 12/17/2018 at an average price of $18.6 a share. The total cost of this purchase was $499,652.
The Medicines Co is a pharmaceutical company. It provides transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. The company's products are Angiomax, Ionsys, Minocin for injection and Orbactiv. The Medicines Co has a market cap of $1.38 billion; its shares were traded at around $18.69 with and P/S ratio of 93.94.
CEO Recent Trades:
- CEO Mark Timney bought 26,863 shares of MDCO stock on 12/17/2018 at the average price of $18.6. The price of the stock has increased by 0.48% since.
Directors and Officers Recent Trades:
- Director Alexander J Denner bought 30,000 shares of MDCO stock on 12/18/2018 at the average price of $18. The price of the stock has increased by 3.83% since.
- Director Alexander J Denner bought 819,000 shares of MDCO stock on 12/14/2018 at the average price of $20.26. The price of the stock has decreased by 7.75% since.
For the complete insider trading history of MDCO, click here
.
